C Meregalli

Novel Therapeutic Strategy to Prevent Chemotherapy-Induced Persistent Sensory Neuropathy By TRPA1 Blockade

Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl/6 mice

An Overview of Animal Models of Pain: Disease Models and Outcome Measures

Sphingolipids and their metabolism in physiology and disease

Guillain-Barré syndrome

Methods Used to Evaluate Pain Behaviors in Rodents

Chemotherapy-induced peripheral neurotoxicity (CIPN): An update

Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis

Increased Plasma Levels of Select Deoxy-ceramide and Ceramide Species are Associated with Increased Odds of Diabetic Neuropathy in Type 1 Diabetes: A Pilot Study

β-Lactam analogues of combretastatin A-4 prevent metabolic inactivation by glucuronidation in chemoresistant HT-29 colon cancer cells

Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy

Mechanisms of distal axonal degeneration in peripheral neuropathies

Chemotherapy-induced peripheral neurotoxicity

Bortezomib alters microtubule polymerization and axonal transport in rat dorsal root ganglion neurons

SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization

Interventions for preventing neuropathy caused by cisplatin and related compounds

An Updated Understanding of the Mechanisms Involved in cHemotherapy-Induced Neuropathy

Neuropathic Pain: From Mechanisms to Treatment

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

The mechanosensitive ion channel Piezo2 mediates sensitivity to mechanical pain in mice

Plasma 1-deoxysphingolipids are predictive biomarkers for type 2 diabetes mellitus

Neurophysiological and neuropathological evaluation of the bortezomib effect in myeloma-bearing mice

Bortezomib‐induced painful neuropathy in rats: A behavioral, neurophysiological and pathological study in rats

Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies

A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer

Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy

Lowering Plasma 1-Deoxysphingolipids Improves Neuropathy in Diabetic Rats

Bortezomib Treatment Produces Nocifensive Behavior and Changes in the Expression of TRPV1, CGRP, and Substance P in the Rat DRG, Spinal Cord, and Sciatic Nerve